Jiangsu Hengrui Medicine
600276.SS
#494
Rank
HK$314.21 B
Marketcap
HK$49.26
Share price
-0.62%
Change (1 day)
1.08%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$4.44 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are HK$4.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31HK$4.46 B-1.22%
2021-12-31HK$4.52 B-3.53%
2020-12-31HK$4.68 B60.5%
2019-12-31HK$2.91 B-0.86%
2018-12-31HK$2.94 B16.99%
2017-12-31HK$2.51 B54.86%
2016-12-31HK$1.62 B19.35%
2015-12-31HK$1.36 B16.53%
2014-12-31HK$1.16 B61.62%
2013-12-31HK$0.72 B29.26%
2012-12-31HK$0.55 B3.01%
2011-12-31HK$0.54 B9.66%
2010-12-31HK$0.49 B30.68%
2009-12-31HK$0.37 B45.33%
2008-12-31HK$0.26 B-39.4%
2007-12-31HK$0.43 B114.8%
2006-12-31HK$0.20 B17.71%
2005-12-31HK$0.17 B-29.65%
2004-12-31HK$0.24 B-52.86%
2003-12-31HK$0.51 B38.03%
2002-12-31HK$0.37 B9.31%
2001-12-31HK$0.34 B